Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Trading Statement

12 Apr 2018 07:00

RNS Number : 6330K
Scapa Group PLC
12 April 2018
 

 

12 April 2018

 

Scapa Group plc ("Scapa" or "the Group")

 

Year-end trading update

 

Scapa Group plc (AIM: SCPA) is today providing an unaudited year end update for the twelve months ended 31 March 2018.  

 

The Group performed well and the good progress reported in the Interim Results has continued. Overall Group results are in line with the improved expectations outlined in the Group's October trading update.

Healthcare: Revenues grew 3.8% for the year, despite currency headwinds in H2. Sales growth in H2 was strong at 6.8% on a constant currency basis. Margins for the year are expected to be above 15% reflecting the investment in the integration of two technology transfers completed during the year.

Industrial: Industrial continues to deliver on its asset optimisation strategy. Industrial margin further improved driven by the benefit of Asian restructuring and more efficient cost to serve. The Markel acquisition is complete and site consolidations are underway.

Healthy cash flow in the period ensured the Group ended the year with net debt of ÂŁ3.8m, after the acquisition of Markel Industries for US$10.2m (ÂŁ7.6m) and BioMed Laboratories LLC for US$19m (ÂŁ13.6m).

Heejae Chae, CEO commented:

"This year we have delivered another set of strong results, and completed two acquisitions: Markel, our first Industrial acquisition, and BioMed, our first Healthcare acquisition outside adhesive technology. We also completed two technology transfers in Healthcare as we execute our growth strategy. I believe there is clear potential, in both Healthcare and Industrial, to further improve performance through organic growth, efficiency and acquisitions.

It is with great sadness that we announced yesterday a fatal accident at the Dunstable facility in the UK. I join with all of my colleagues and fellow directors in expressing our sincere condolences to the family and friends of the deceased."

Scapa expects to report its full year results on 22 May 2018.

This announcement contains inside information.

For further information:

Scapa Group plc Heejae Chae - Chief Executive Tel: 0161 301 7430

Graham Hardcastle - Finance Director

 

Numis Securities Limited Mark Lander, Richard Thomas Tel: 020 7260 1000

(Nominated Adviser/Joint Broker)

 

Berenberg Chris Bowman Tel: 020 3207 7800

(Joint Broker)

 

Weber Shandwick Financial PR Nick Oborne Tel: 0207 067 0000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFKDDPPBKDBQD
Date   Source Headline
23rd Dec 20143:48 pmRNSHolding(s) in Company
10th Dec 20141:09 pmRNSHolding(s) in Company
2nd Dec 201410:00 amRNSDirectorate Change
1st Dec 201410:07 amRNSHolding(s) in Company
1st Dec 201410:03 amRNSHolding(s) in Company
26th Nov 20142:09 pmRNSAdditional Listing
25th Nov 20147:00 amRNSHalf Yearly Report
24th Nov 20149:08 amRNSHolding(s) in Company
18th Nov 20149:27 amRNSHolding(s) in Company
29th Oct 20143:33 pmRNSHolding(s) in Company
9th Oct 20147:00 amRNSTrading Statement
11th Aug 20147:00 amRNSDirector/PDMR Shareholding
7th Aug 20147:00 amRNSBlocklisting Interim Review
6th Aug 20149:03 amRNSDirector/PDMR Shareholding
23rd Jul 20147:00 amRNSDirector/PDMR Shareholding
22nd Jul 20145:04 pmRNSHolding(s) in Company
22nd Jul 20147:00 amRNSAGM Statement
11th Jun 20147:00 amRNSCompany Listing
9th Jun 20147:00 amRNSDirector/PDMR Shareholding
30th May 20143:44 pmRNSHolding(s) in Company
28th May 20147:00 amRNSFinal Results
16th May 20149:29 amRNSHolding(s) in Company
13th May 20143:08 pmRNSHolding(s) in Company
28th Apr 20144:20 pmRNSHolding(s) in Company-AMENDMENT
25th Apr 20142:58 pmRNSHolding(s) in Company
11th Apr 20149:45 amRNSHolding(s) in Company
10th Apr 20147:00 amRNSTrading Statement
3rd Apr 201410:24 amRNSAdditional Listing
13th Mar 20145:17 pmRNSHolding(s) in Company
12th Mar 20142:31 pmRNSAdditional Listing
6th Mar 20149:23 amRNSHolding(s) in Company
3rd Mar 20141:11 pmRNSHolding(s) in Company
18th Feb 20143:52 pmRNSHolding(s) in Company
7th Feb 20147:00 amRNSBlocklisting Interim Review
6th Feb 20147:00 amRNSMerger of UK Pension Schemes
29th Jan 20147:00 amRNSNew Finance Facility
9th Jan 20149:12 amRNSHolding(s) in Company
20th Dec 20138:42 amRNSHolding(s) in Company
11th Dec 20135:21 pmRNSHolding(s) in Company
11th Dec 20137:00 amRNSDirector/PDMR Shareholding
10th Dec 20137:00 amRNSDirector/PDMR Shareholding
26th Nov 20137:00 amRNSHalf Yearly Report
25th Nov 20134:09 pmRNSHolding(s) in Company
5th Nov 201312:11 pmRNSHolding(s) in Company
10th Oct 20137:00 amRNSTrading Statement
27th Sep 20137:00 amRNSHolding(s) in Company
7th Aug 20134:52 pmRNSHolding(s) in Company
7th Aug 20138:57 amRNSBlocklisting Interim Review
26th Jul 20138:47 amRNSHolding(s) in Company
26th Jul 20138:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.